ICON Biotech surveyed 163 biotech leaders in North America, EMEA and APAC to see how they are responding to the headwinds.
Deepali Suri
Advertisement
Deepali Suri is president at ICON Biotech.
Articles by Deepali Suri
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs
2
Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics
3
Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
5